Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Twitter Promo Study Gets Tweaks, But FDA Rejects Many Industry Suggestions

Jul 18 2017

• By Brenda Sandburg

Women hand holding smartphone and using Twitter application

Related Content

FDA Changes Own Tweets To Match Industry Guidance

Sep 22 2014

FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks

Jun 18 2014

Rx Ad Studies Target Risk Info Location, Efficacy Framing, Oncology Products

Jul 10 2017

Twitter Rx Drug Promos: FDA Studies Best Way To Convey Risk Info

Nov 05 2016

Related Companies

Eli Lilly and Company

AbbVie Inc.

Additional Topics

United States Advertising, Marketing & Sales FDA Regulation BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window